Search details
1.
China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.
Int J Cancer
; 153(11): 1916-1927, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-36946696
2.
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.
Int J Cancer
; 152(1): 79-89, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36062503
3.
Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial.
J Transl Med
; 21(1): 411, 2023 06 24.
Article
in English
| MEDLINE | ID: mdl-37355621
4.
Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer.
J Transl Med
; 21(1): 63, 2023 01 30.
Article
in English
| MEDLINE | ID: mdl-36717891
5.
Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.
BMC Med
; 20(1): 133, 2022 04 21.
Article
in English
| MEDLINE | ID: mdl-35443723
6.
ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors.
BMC Med
; 20(1): 170, 2022 05 05.
Article
in English
| MEDLINE | ID: mdl-35509036
7.
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
BMC Cancer
; 21(1): 282, 2021 Mar 16.
Article
in English
| MEDLINE | ID: mdl-33726687
8.
Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
Oncology
; 98(8): 583-588, 2020.
Article
in English
| MEDLINE | ID: mdl-32521533
9.
An exploration of gastric cancer with heterogeneous mismatch repair status.
Virchows Arch
; 482(3): 517-523, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36754896
10.
Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma.
Front Immunol
; 14: 1116057, 2023.
Article
in English
| MEDLINE | ID: mdl-37056769
11.
Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis.
Cancer Res Treat
; 55(2): 626-635, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36550683
12.
ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
Adv Sci (Weinh)
; 10(24): e2300881, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37341301
13.
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial.
J Immunother Cancer
; 11(9)2023 09.
Article
in English
| MEDLINE | ID: mdl-37730273
14.
Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
J Immunother Cancer
; 10(3)2022 03.
Article
in English
| MEDLINE | ID: mdl-35241494
15.
Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients.
Front Oncol
; 12: 898916, 2022.
Article
in English
| MEDLINE | ID: mdl-36147908
16.
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients.
Transl Lung Cancer Res
; 11(2): 263-276, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35280315
17.
Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers.
Front Immunol
; 13: 811601, 2022.
Article
in English
| MEDLINE | ID: mdl-35265073
18.
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.
J Immunother Cancer
; 10(6)2022 06.
Article
in English
| MEDLINE | ID: mdl-35705314
19.
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study.
Transl Lung Cancer Res
; 11(12): 2539-2566, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36636408
20.
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma.
Nat Commun
; 13(1): 5378, 2022 09 14.
Article
in English
| MEDLINE | ID: mdl-36104359